Metabolic Derangements in Acute Heart Failure Syndrome
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00682175 |
Recruitment Status
:
Terminated
(Project not initiated)
First Posted
: May 22, 2008
Last Update Posted
: March 26, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Congestive Heart Failure | Other: Observational |
Study Type : | Observational |
Estimated Enrollment : | 100 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Metabolic Derangements in Acute Heart Failure Syndrome |
Study Start Date : | May 2008 |
Actual Primary Completion Date : | March 2009 |
Actual Study Completion Date : | March 2009 |
Group/Cohort | Intervention/treatment |
---|---|
Observation
Adult (age > 18 yrs) patients admitted to the Heart Failure Intensive Care Unit with Acute Heart Failure Syndrome requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy.
|
Other: Observational
Pulmonary Artery pressure (PA), pulmonary capillary wedge pressure (PCWP), cardiac output (CO), and cardiac index (CI). This data will be collected after 24 ± 2 and 48 ± 2 hours of standard heart failure therapy
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Adult (age > 18 yrs) patients admitted to the Heart Failure Intensive Care Unit (H22) with Acute Heart Failure Syndrome (AHFS) requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy.
Exclusion Criteria:
- History of Congenital Heart Disease.
- Acute HF in the setting of acute myocardial infarction.
- Severe Anemia
- Patients listed for cardiac transplantation.
- Terminal Malignancy, AIDS or CNS disease.
- Concomitant sepsis, ARDS, trauma, aortic dissection, or pericardial tamponade

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00682175
Principal Investigator: | George Sokos, MD | The Cleveland Clinic |
Responsible Party: | George Sokos, MD, Cleveland Clinic Foundation |
ClinicalTrials.gov Identifier: | NCT00682175 History of Changes |
Other Study ID Numbers: |
08-169 |
First Posted: | May 22, 2008 Key Record Dates |
Last Update Posted: | March 26, 2009 |
Last Verified: | March 2009 |
Keywords provided by The Cleveland Clinic:
Congestive Heart Failure |
Additional relevant MeSH terms:
Heart Failure Metabolic Diseases Heart Diseases Cardiovascular Diseases |